Hologic(HOLX) Stock Price Today | Quotes & News

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

HOLX Hologic

Watchlist

61.470
-0.510-0.82%

Close Mar 19 16:00 ET

61.470
0.0000.00%

Post 20:01 ET

13.79BMarket Cap19.45P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | FOMC Projects Lower GDP and Uncertainty, No Rate Change
Moomoo News13:50 ET
Fed Dot Plot in Full View as Market Holds on a Higher Note: Live Stock News
Kevin TraversMar 19 10:40 ET
HOLX Stock Down 24.7% in 6 Months: Time to Cut Losses or Buy the Dip?
Zacks Mar 19 09:05 ET
Redburn Atlantic Adjusts Hologic Price Target to $72 From $82, Keeps Neutral Rating
MT NewswiresMar 18 12:31 ET · Ratings
Green Gives Way to Red on Gossamer Macro Expectations: Live Stock News
Kevin TraversMar 18 10:32 ET
Hologic (HOLX) Beats Stock Market Upswing: What Investors Need to Know
Yahoo FinanceMar 17 17:45 ET

Comments

Teddy123

Feb 20 18:50

Hologic Obtains CE Mark for Affirm® Contrast Biopsy Software

$Hologic (HOLX.US)$
Can This New Biopsy Technology Transform Breast Cancer Detection in Europe?

BAO BMW

Feb 19 17:08

$Primega Group (PGHL.US)$ and $Hologic (HOLX.US)$ both are china company..stay away ..unless u love 刺激..专割人韭菜。逢买必跌..

Primega Group(PGHL) 0.723 -3.06%

Teddy123

Feb 18 21:15

Hologic Announces FDA Clearance of Aptima SARS-CoV-2 Assay

$Hologic (HOLX.US)$
Major FDA Breakthrough: This Revolutionary COVID Test Delivers Results 3X Faster

Trytosaveabit

Apr 12, 2024 02:11

Update

$Hologic (HOLX.US)$ Bayer and Hologic Collaborating to Deliver Contrast-Enhanced Mammography 3 MINUTES AGO, 2:07 PM EDT VIA BUSINESSWIRE Collaboration Includes Robust Education and Training to Support Radiologists and Imaging Specialists Bayer and Hologic, Inc. (NASDAQ:HOLX) today announced a first-of-its-kind collaboration to deliver a coordinated solution for contrast-enhanced mammography (CEM). The two ...

Moomoo AI

Feb 12, 2024 23:38

Multiple insiders selling shares could be a red flag. The absence of insider purchases and significant selling over the last three months may suggest insiders believe the shares are overpriced. Despite high insider ownership, the lack of buying and significant selling raises concerns about the company.